000 01500 a2200421 4500
005 20250516210433.0
264 0 _c20150112
008 201501s 0 0 eng d
022 _a1473-656X
024 7 _a10.1097/GCO.0000000000000060
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDiergaarde, Brenda
245 0 0 _aUse of fertility drugs and risk of ovarian cancer.
_h[electronic resource]
260 _bCurrent opinion in obstetrics & gynecology
_cJun 2014
300 _a125-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAdult
650 0 4 _aCase-Control Studies
650 0 4 _aClomiphene
_xadministration & dosage
650 0 4 _aEstrogens
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFertility Agents, Female
_xadministration & dosage
650 0 4 _aGenes, BRCA1
_xdrug effects
650 0 4 _aGenes, BRCA2
_xdrug effects
650 0 4 _aGonadotropins
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInfertility, Female
_xtherapy
650 0 4 _aMutation
650 0 4 _aOvarian Neoplasms
_xchemically induced
650 0 4 _aOvulation Induction
_xadverse effects
650 0 4 _aParity
650 0 4 _aPregnancy
650 0 4 _aRisk Factors
650 0 4 _aTime Factors
700 1 _aKurta, Michelle L
773 0 _tCurrent opinion in obstetrics & gynecology
_gvol. 26
_gno. 3
_gp. 125-9
856 4 0 _uhttps://doi.org/10.1097/GCO.0000000000000060
_zAvailable from publisher's website
999 _c23755902
_d23755902